SOL Global Announces Update to Normal Course Issuer Bid for Purchase of 5% of Company’s Common Shares

Core Portfolio Company Wesana Health Inc. Publicly Lists on CSE

Basic Number of Issued and Outstanding Shares Now Reduced to 53,217,538

Toronto, ON – May 10, 2021 – SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) is pleased to announce that it has purchased an aggregate of 1,538,800 common shares in the capital of the Company (“Common Shares”) during the current purchase cycle pursuant to the Company’s previously announced normal course issuer bid (“NCIB”), which commenced on March 31, 2021. A maximum of 2,737,805 Common Shares may be purchased pursuant to the NCIB, representing approximately 5% of the issued and outstanding Common Shares as at the time of the commencement of the NCIB. To date, an aggregate of 1,538,800 Common Shares have been purchased by the Company under the NCIB through the facilities of the Canadian Securities Exchange at an average purchase price of $4.3831 per share.

There are 53,217,538 Common Shares issued and outstanding as of the current date. An additional 1,199,005 Common Shares may be purchased by the Company under the NCIB. The Company intends to repurchase the full 5% and will be updating the market on the progress of its NCIB on a monthly basis. The NCIB is expected to terminate on March 31, 2022, or such earlier date at the discretion of the Company or upon the completion of the purchase of the maximum number of Common Shares under the NCIB.

“We continue to buy our stock back which is evidence of our overwhelming confidence in our portfolio companies” said SOL Global’s Chairman and CEO, Andy DeFrancesco. “Due to blackout restrictions, we have not been buying for last few weeks, but will immediately start again when permitted.”